Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report-Reference-Cited by-同舟云学术

Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report

Published:2019-01-03 Issue:1 Volume:30 Page:24-35
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Suzuki Yasuo¹,Sugiyama Naonobu²,Fukuma Yuri²,Sugiyama Noriko³,Kokubo Takeshi³

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan;

2. Medical Affairs, Pfizer Japan Inc., Tokyo, Japan;

3. Development Japan, Pfizer Japan Inc., Tokyo, Japan

Funder

Pfizer Japan Inc

Sawai Pharmaceutical Co., Ltd.

Shiono Chemical Co., Ltd.

Mitsubishi- Tanabe Pharma Corporation

Towa Pharmaceutical Co., Ltd.

Sandoz Co. Ltd.

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2018.1532483

Reference33 articles.

1. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

2. Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose

3. Japan College of Rheumatology/Institute of Information Analysis. Studies on the effectiveness and safety of methotrexate (MTX) given at doses >8 mg/week: results from 3 RA patient cohort database studies in Japan (IORRA, REAL and NinJa) (in Japanese). Available from: https://www.ryumachi-jp.com/pdf/MTXHighdose.pdf [last accessed 18 Feb 2016]

4. Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensive treatment for the progression of joint damage in rheumatoid arthritis patients with low disease activity or remission;Modern Rheumatology;2023-06-02

2. Predictive factors for retention of golimumab over a median 4‐year duration in Japanese patients with rheumatoid arthritis in a real‐world setting: A retrospective study and literature review;International Journal of Rheumatic Diseases;2022-01-06

3. Post-marketing surveillance of high-dose methotrexate (>8 mg/week) in Japanese patients with rheumatoid arthritis: A post hoc sub-analysis of patients according to duration of prior methotrexate use;Modern Rheumatology;2021-01-21

4. RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report;Modern Rheumatology;2017-04-11